Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (481-490 of 921) with videos related to

Pageof 93
Sort By:
International Journal of Oncology|August 4, 2005
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysisThorsten Schlomm, Andreas M Luebke, Holger Sültmann, et al.
Deutsches Arzteblatt International|June 24, 2025
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 PatientsMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2025
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomyMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Cancer Research|March 16, 2013
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancerLia Burkhardt, Sarah Fuchs, Antje Krohn, et al.
Urologic Oncology|May 15, 2016
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European studyMassimo Lazzeri, Giovanni Lughezzani, Alexander Haese, et al.
BJU International|March 16, 2017
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimensStefan Steurer, Sebastian Dwertmann Rico, Ronald Simon, et al.
Clinical Genitourinary Cancer|August 4, 2019
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate CancerFelix Preisser, Sebastiano Nazzani, Elio Mazzone, et al.
European Urology|December 19, 2009
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomyGiovanni Lughezzani, Lars Budäus, Hendrik Isbarn, et al.
World Journal of Urology|December 2, 2024
Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysisFrancesca Ambrosini, Johanna Hagemann, Randi Pose, et al.
BJU International|July 10, 2024
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancerMike Wenzel, Benedikt Hoeh, Florestan Koll, et al.
Pageof 93

Showing results (481-490 of 921) with videos related to

Sort By:
Pageof 93
International Journal of Oncology|August 4, 2005
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysisThorsten Schlomm, Andreas M Luebke, Holger Sültmann, et al.
Deutsches Arzteblatt International|June 24, 2025
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 PatientsMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2025
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomyMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Cancer Research|March 16, 2013
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancerLia Burkhardt, Sarah Fuchs, Antje Krohn, et al.
Urologic Oncology|May 15, 2016
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European studyMassimo Lazzeri, Giovanni Lughezzani, Alexander Haese, et al.
BJU International|March 16, 2017
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimensStefan Steurer, Sebastian Dwertmann Rico, Ronald Simon, et al.
Clinical Genitourinary Cancer|August 4, 2019
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate CancerFelix Preisser, Sebastiano Nazzani, Elio Mazzone, et al.
European Urology|December 19, 2009
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomyGiovanni Lughezzani, Lars Budäus, Hendrik Isbarn, et al.
World Journal of Urology|December 2, 2024
Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysisFrancesca Ambrosini, Johanna Hagemann, Randi Pose, et al.
BJU International|July 10, 2024
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancerMike Wenzel, Benedikt Hoeh, Florestan Koll, et al.
Pageof 93